Coston McIsaac & Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Hold
51
﹤0.01% 733
2026
Q1
$3K Hold
51
﹤0.01% 721
2025
Q4
$4K Hold
51
﹤0.01% 678
2025
Q3
$3K Hold
51
﹤0.01% 682
2025
Q2
$3K Sell
51
-17
-25% -$1.18K ﹤0.01% 660
2025
Q1
$5K Hold
68
﹤0.01% 590
2024
Q4
$5K Sell
68
-177
-72% -$15K ﹤0.01% 577
2024
Q3
$22 Buy
245
+177
+260% +$14.9K 0.01% 384
2024
Q2
$5K Sell
68
-74
-52% -$6.04K ﹤0.01% 558
2024
Q1
$12K Sell
142
-61
-30% -$5.08K ﹤0.01% 451
2023
Q4
$15K Hold
203
0.01% 426
2023
Q3
$13K Buy
203
+61
+43% +$4.44K ﹤0.01% 440
2023
Q2
$11K Hold
142
﹤0.01% 486
2023
Q1
$11K Buy
+142
New +$10.1K ﹤0.01% 480

Other funds holding GEHC

Coston McIsaac & Partners's GEHC Position: Q2 2026 in Review

Coston McIsaac & Partners held its GE HealthCare (GEHC) position steady in Q2 2026 at 51 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Coston McIsaac & Partners first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $15K in Q4 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Coston McIsaac & Partners held 51 shares of GE HealthCare worth $3K as of Q2 2026.
  • Coston McIsaac & Partners left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #733 holding.
  • Coston McIsaac & Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Coston McIsaac & Partners's GE HealthCare position peaked at $15K in Q4 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.